The evaluation of short- and long-term risk for developing cancer in patients with ... KRAS mutation Any polyp 4 CIMP negative, MSS Adenoma-carcinoma sequence 5 (Lynch syndrome) CIMP negative ...

Colon cancer is the disease characterized by ... use a model that recapitulates the colon adenoma–carcinoma transition through the sequential elimination of media factors leading to spontaneous ...

Targeted therapy revolutionized cancer treatment, with gene fusions leading the way when the FDA approved imatinib in 2001 to ...

First patient dosed in Phase 1 clinical trial evaluating ZW171 in advanced mesothelin (MSLN)-expressing cancers Preclinical data presented on ...

Immunocore (NASDAQ:IMCR – Get Free Report) and Prime Medicine (NYSE:PRME – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses ...

Alloplex said in a statement that it will evaluate whether treatment with Suplexa improves patient outcomes by amplifying the effect of immune checkpoint inhibitors in patients with a certain type of ...

Squamous cell carcinoma of the head and neck (HNSCC ... The nanomedicine is emerging as a promising strategy to achieve maximal anti-tumor effect in cancer therapy. In this review, we summarize some ...

Carcinoma ex pleomorphic adenoma (CXPA) is a rare type of salivary gland cancer. Surgery and radiation therapy are the most common treatment options. CXPA develops from a noncancerous tumor called ...

The most important takeaway from the study is that these data suggest that CD47 is an attractive target for drug development.

A recent prospective cross-sectional study in Thailand demonstrates that multitarget stool DNA testing is highly sensitive ...

Investigation shows how bacterial adhesins contribute to colon cancer mutations, suggesting new avenues for therapeutic ...